|
| |
| | | 57460 | | 22.11.2007 | | Future Health Pharma GmbH | | | | | | | | | | | | | 01.01.30. | | | | 01.01.30. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Matrifen 25 ug/h | Transdermales Pflaster | Transdermales Therapeutisches System (Fentanyl 2.75 mg) | N02AB03 | PI | | 02 | Matrifen 50 ug/h | Transdermales Pflaster | Transdermales Therapeutisches System (Fentanyl 5.5 mg) | N02AB03 | PI | | 03 | Matrifen 75 ug/h | Transdermales Pflaster | Transdermales Therapeutisches System (Fentanyl 8.25 mg) | N02AB03 | PI | | 04 | Matrifen 100 ug/h | Transdermales Pflaster | Transdermales Therapeutisches System (Fentanyl 11 mg) | N02AB03 | PI | | 05 | Matrifen 12 ug/h | Transdermales Pflaster | Transdermales Therapeutisches System (Fentanyl 1.38 mg) | N02AB03 | PI |
|
|
|
